Clinical Trials Logo
  1. Home
  2. Muscular Dystrophies
  3. NCT02685215

Prognostic Factors , Morbidity and Mortality in Patients With Neuromuscular Disorders Admitted in ICU

Muscular Dystrophies Clinical Trial

Official title:
Prognostic Factors, Morbidity, Mortality and Long Term Survival in Patients With Neuromuscular Disorders Admitted in Intensive Care Unit

Clinical Trial Summary

Muscular dystrophies are neuromuscular disorders with disability. Restrictive pulmonary failure and cardiomyopathy affect prognosis.The investigators aim to establish predictive factors for mortality and morbidity in Intensive care unit (ICU ) and to describe the long term follow up after ICU discharge.

Clinical Trial Description

Muscular dystrophies are neuromuscular disorders with disability. Restrictive pulmonary failure and cardiomyopathy affect prognosis. Little is known about morbidity and mortality of patients with muscular dystrophies admitted in intensive care unit (ICU).The investigators aim to describe the spectrum of patients with muscular dystrophies admitted in ICU , to establish predictive factors for ICU mortality and morbidity and to describe the long term follow up after ICU discharge. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02685215
Study type Observational
Source Centre d'Investigation Clinique et Technologique 805
Contact
Status Active, not recruiting
Phase
Start date March 2016
Completion date December 2019
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01480245 - Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy Phase 3
Completed NCT01153932 - Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy Phase 2
Completed NCT00027391 - Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) N/A
Recruiting NCT04392518 - Telerehabilitation in Proximal Muscle Weakness N/A
Completed NCT03851107 - The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities N/A
Completed NCT01462292 - A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) Phase 2
Recruiting NCT06094205 - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) N/A
Recruiting NCT05724173 - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia N/A
Recruiting NCT03698149 - ECoG BMI for Motor and Speech Control N/A
Active, not recruiting NCT03811301 - [BrainConnexion] - Neurodevice Phase I Trial N/A
Completed NCT05881122 - Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability N/A
Completed NCT04154098 - Evaluation of a Textile Scapula Orthosis N/A
Recruiting NCT05409079 - Schulze Muscular Dystrophy Ability Clinical Study N/A
Enrolling by invitation NCT04009408 - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders N/A
Active, not recruiting NCT00674843 - The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies Phase 1
Recruiting NCT02109692 - Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies N/A
Active, not recruiting NCT04045158 - Diaphragm Ultrasound in Neuromuscular Disorders
Not yet recruiting NCT03508583 - Turkish Version of The Measure of Processes of Care (MPOC)
Terminated NCT01803412 - A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects Phase 3
Completed NCT03406780 - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Phase 2